Commentary
COVID-19 has predominantly targeted vulnerable populations with pre-existing chronic medical diseases, such as diabetes and chronic liver disease. D. Kim et al. (Stanford University School of Medicine, USA) estimated chronic liver disease-related mortality trends among individuals with diabetes before and during the COVID-19 pandemic utilising the US national mortality database and Census.
The authors conclude: “The sharp increase in mortality for chronic liver disease and/or cirrhosis among individuals with diabetes during the COVID-19 pandemic was associated with increased mortality from NAFLD and alcohol-related liver disease.”
